• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rab-GTPase 结合效应蛋白 2(RABEP2)是糖原合酶激酶-3(GSK3)的预激活底物。

Rab-GTPase binding effector protein 2 (RABEP2) is a primed substrate for Glycogen Synthase kinase-3 (GSK3).

机构信息

Division of Molecular and Clinical Medicine, University of Dundee, Dundee, UK.

MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dundee, UK.

出版信息

Sci Rep. 2017 Dec 15;7(1):17682. doi: 10.1038/s41598-017-17087-6.

DOI:10.1038/s41598-017-17087-6
PMID:29247183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5732219/
Abstract

Glycogen synthase kinase-3 (GSK3) regulates many physiological processes through phosphorylation of a diverse array of substrates. Inhibitors of GSK3 have been generated as potential therapies in several diseases, however the vital role GSK3 plays in cell biology makes the clinical use of GSK3 inhibitors potentially problematic. A clearer understanding of true physiological and pathophysiological substrates of GSK3 should provide opportunities for more selective, disease specific, manipulation of GSK3. To identify kinetically favourable substrates we performed a GSK3 substrate screen in heart tissue. Rab-GTPase binding effector protein 2 (RABEP2) was identified as a novel GSK3 substrate and GSK3 phosphorylation of RABEP2 at Ser200 was enhanced by prior phosphorylation at Ser204, fitting the known consensus sequence for GSK3 substrates. Both residues are phosphorylated in cells while only Ser200 phosphorylation is reduced following inhibition of GSK3. RABEP2 function was originally identified as a Rab5 binding protein. We did not observe co-localisation of RABEP2 and Rab5 in cells, while ectopic expression of RABEP2 had no effect on endosomal recycling. The work presented identifies RABEP2 as a novel primed substrate of GSK3, and thus a potential biomarker for GSK3 activity, but understanding how phosphorylation regulates RABEP2 function requires more information on physiological roles of RABEP2.

摘要

糖原合酶激酶-3(GSK3)通过磷酸化多种底物来调节许多生理过程。GSK3 的抑制剂已被作为几种疾病的潜在治疗方法而产生,然而 GSK3 在细胞生物学中所起的重要作用使得 GSK3 抑制剂的临床应用可能存在问题。对 GSK3 的真正生理和病理生理底物有更清楚的了解,应该为更具选择性、针对特定疾病的 GSK3 操作提供机会。为了鉴定动力学有利的底物,我们在心脏组织中进行了 GSK3 底物筛选。Rab-GTPase 结合效应蛋白 2(RABEP2)被鉴定为一种新的 GSK3 底物,并且 RABEP2 的 Ser200 处的 GSK3 磷酸化在前 Ser204 磷酸化的情况下增强,符合 GSK3 底物的已知共有序列。这两个残基在细胞中都被磷酸化,而只有 GSK3 抑制后 Ser200 磷酸化减少。RABEP2 的功能最初被鉴定为 Rab5 结合蛋白。我们没有观察到 RABEP2 和 Rab5 在细胞中的共定位,而 RABEP2 的异位表达对内体再循环没有影响。目前的工作确定 RABEP2 是 GSK3 的一种新型引发底物,因此是 GSK3 活性的潜在生物标志物,但要了解磷酸化如何调节 RABEP2 的功能,需要更多关于 RABEP2 生理作用的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/4c475ebde5e2/41598_2017_17087_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/c71ed554ab40/41598_2017_17087_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/6dcada56cc27/41598_2017_17087_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/128aa4251e37/41598_2017_17087_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/0a174e21969c/41598_2017_17087_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/4c475ebde5e2/41598_2017_17087_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/c71ed554ab40/41598_2017_17087_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/6dcada56cc27/41598_2017_17087_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/128aa4251e37/41598_2017_17087_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/0a174e21969c/41598_2017_17087_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e778/5732219/4c475ebde5e2/41598_2017_17087_Fig5_HTML.jpg

相似文献

1
Rab-GTPase binding effector protein 2 (RABEP2) is a primed substrate for Glycogen Synthase kinase-3 (GSK3).Rab-GTPase 结合效应蛋白 2(RABEP2)是糖原合酶激酶-3(GSK3)的预激活底物。
Sci Rep. 2017 Dec 15;7(1):17682. doi: 10.1038/s41598-017-17087-6.
2
The Rab-effector protein RABEP2 regulates endosomal trafficking to mediate vascular endothelial growth factor receptor-2 (VEGFR2)-dependent signaling.Rab 效应蛋白 RABEP2 调节内体运输,从而介导血管内皮生长因子受体-2(VEGFR2)依赖性信号转导。
J Biol Chem. 2018 Mar 30;293(13):4805-4817. doi: 10.1074/jbc.M117.812172. Epub 2018 Feb 7.
3
FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation.FRAT-2优先增加糖原合酶激酶3β介导的引发位点的磷酸化,这导致tau蛋白磷酸化增强。
J Biol Chem. 2005 Jan 7;280(1):270-6. doi: 10.1074/jbc.M410061200. Epub 2004 Nov 1.
4
Insulin receptor substrate-2 phosphorylation is necessary for protein kinase C zeta activation by insulin in L6hIR cells.胰岛素受体底物-2磷酸化对于L6hIR细胞中胰岛素激活蛋白激酶Cζ是必需的。
J Biol Chem. 2001 Oct 5;276(40):37109-19. doi: 10.1074/jbc.M104405200. Epub 2001 Jul 31.
5
The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.激酶DYRK使蛋白质合成起始因子eIF2Bε在丝氨酸539位点磷酸化,并使微管相关蛋白tau在苏氨酸212位点磷酸化:DYRK作为糖原合酶激酶3引发激酶的潜在作用。
Biochem J. 2001 May 1;355(Pt 3):609-15. doi: 10.1042/bj3550609.
6
Differential effects of glycogen synthase kinase 3 (GSK3) inhibition by lithium or selective inhibitors in the central nervous system.锂或选择性抑制剂对中枢神经系统糖原合酶激酶 3(GSK3)抑制的差异作用。
Naunyn Schmiedebergs Arch Pharmacol. 2013 Oct;386(10):893-903. doi: 10.1007/s00210-013-0893-9. Epub 2013 Jun 22.
7
Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.急性选择性糖原合酶激酶-3抑制增强糖尿病前期胰岛素抵抗大鼠骨骼肌中的胰岛素信号传导。
Am J Physiol Endocrinol Metab. 2005 Jun;288(6):E1188-94. doi: 10.1152/ajpendo.00547.2004. Epub 2005 Jan 25.
8
Bioinformatic prediction and confirmation of beta-adducin as a novel substrate of glycogen synthase kinase 3.生物信息学预测和确证β-辅肌动蛋白是糖原合酶激酶 3 的一个新底物。
J Biol Chem. 2011 Jul 15;286(28):25274-83. doi: 10.1074/jbc.M111.251629. Epub 2011 May 23.
9
GSK3 and its interactions with the PI3K/AKT/mTOR signalling network.糖原合成酶激酶3及其与磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白信号网络的相互作用
Adv Biol Regul. 2017 Aug;65:5-15. doi: 10.1016/j.jbior.2017.06.003. Epub 2017 Jun 27.
10
Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase.糖原合酶激酶3是一种受胰岛素调节的C/EBPα激酶。
Mol Cell Biol. 1999 Dec;19(12):8433-41. doi: 10.1128/MCB.19.12.8433.

引用本文的文献

1
Genetic Commonalities Between Metabolic Syndrome and Rheumatic Diseases Through Disease Interactome Modules.通过疾病相互作用组模块探讨代谢综合征与风湿性疾病之间的遗传共性
J Cell Mol Med. 2025 Jan;29(1):e70329. doi: 10.1111/jcmm.70329.
2
Case Report: Novel Copy Number Variant 16p11.2 Duplication Associated With Prune Belly Syndrome.病例报告:与梅干腹综合征相关的新型16p11.2拷贝数变异重复
Front Pediatr. 2021 Sep 23;9:729932. doi: 10.3389/fped.2021.729932. eCollection 2021.
3
Collateral Vessels Have Unique Endothelial and Smooth Muscle Cell Phenotypes.

本文引用的文献

1
Phosphoproteomics reveals that glycogen synthase kinase-3 phosphorylates multiple splicing factors and is associated with alternative splicing.磷酸化蛋白质组学研究表明,糖原合酶激酶-3可磷酸化多种剪接因子,并与可变剪接相关。
J Biol Chem. 2017 Nov 3;292(44):18240-18255. doi: 10.1074/jbc.M117.813527. Epub 2017 Sep 15.
2
Variants of Rab GTPase-Effector Binding Protein-2 Cause Variation in the Collateral Circulation and Severity of Stroke.Rab GTPase效应蛋白结合蛋白2的变体导致侧支循环和中风严重程度的差异。
Stroke. 2016 Dec;47(12):3022-3031. doi: 10.1161/STROKEAHA.116.014160. Epub 2016 Nov 3.
3
SDCCAG8 Interacts with RAB Effector Proteins RABEP2 and ERC1 and Is Required for Hedgehog Signaling.
侧支血管具有独特的内皮和平滑肌细胞表型。
Int J Mol Sci. 2019 Jul 24;20(15):3608. doi: 10.3390/ijms20153608.
4
Effects of HIV-1 Tat on oligodendrocyte viability are mediated by CaMKIIβ-GSK3β interactions.HIV-1 Tat 通过 CaMKIIβ-GSK3β 相互作用影响少突胶质细胞活力。
J Neurochem. 2019 Apr;149(1):98-110. doi: 10.1111/jnc.14668. Epub 2019 Mar 15.
SDCCAG8与RAB效应蛋白RABEP2和ERC1相互作用,是刺猬信号通路所必需的。
PLoS One. 2016 May 25;11(5):e0156081. doi: 10.1371/journal.pone.0156081. eCollection 2016.
4
A first-in-human phase I dose-escalation, pharmacokinetic, and pharmacodynamic evaluation of intravenous LY2090314, a glycogen synthase kinase 3 inhibitor, administered in combination with pemetrexed and carboplatin.糖原合酶激酶3抑制剂静脉注射LY2090314与培美曲塞和卡铂联合给药的首次人体I期剂量递增、药代动力学和药效学评估。
Invest New Drugs. 2015 Dec;33(6):1187-96. doi: 10.1007/s10637-015-0278-7. Epub 2015 Sep 25.
5
PKB/SGK-dependent GSK3-phosphorylation in the regulation of LPS-induced Ca2+ increase in mouse dendritic cells.PKB/SGK 依赖性 GSK3 磷酸化在 LPS 诱导的小鼠树突状细胞内钙离子增加中的调节作用。
Biochem Biophys Res Commun. 2013 Aug 2;437(3):336-41. doi: 10.1016/j.bbrc.2013.06.075. Epub 2013 Jun 28.
6
Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3.糖原合酶激酶-3 对 Th1 细胞和实验性自身免疫性脑脊髓炎的调节作用。
J Immunol. 2013 May 15;190(10):5000-11. doi: 10.4049/jimmunol.1203057. Epub 2013 Apr 19.
7
GSK-3α is a central regulator of age-related pathologies in mice.GSK-3α 是小鼠与年龄相关病理的核心调节因子。
J Clin Invest. 2013 Apr;123(4):1821-32. doi: 10.1172/JCI64398. Epub 2013 Mar 15.
8
Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.抑制 GSK3β 介导的 BACE1 表达可减轻阿尔茨海默病相关表型。
J Clin Invest. 2013 Jan;123(1):224-35. doi: 10.1172/JCI64516. Epub 2012 Dec 3.
9
Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies.糖原合酶激酶-3 的抑制可改善阿尔茨海默病小鼠模型中的β-淀粉样蛋白病理,并恢复溶酶体酸化和雷帕霉素靶蛋白的活性:体内和体外研究。
J Biol Chem. 2013 Jan 11;288(2):1295-306. doi: 10.1074/jbc.M112.409250. Epub 2012 Nov 15.
10
GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease.GSK3:开发 2 型糖尿病和阿尔茨海默病新型治疗方法的关键靶点。
Rev Neurosci. 2011 Dec 21;23(1):1-11. doi: 10.1515/rns.2011.061.